Preliminary data published in June 2023 also suggests that GLP-1 drugs 'could modulate crucial pathways in the pathogenesis of inflammatory bowel disease (IBD), such as chronic inflammation circuits, intestinal tight junctions, and gut microbiome dysbiosis, setting the stage for human trials to investigate the role of these agents in the treatment of IBD among people with or without diabetes and obesity' (Arvanitakis, Theocharis, Popovic
Thats because age and chronic illness affect the functional integrity of cell membranes, which has a major impact on the vascular and neurological systems
Your provider can help decide whether continued treatment, maintenance dosing, or lifestyle strategies alone will work best for your situation
In Singapore, GLP-1 medications for weight management require a doctor's assessment and prescription
What to Know Important: Retatrutide remains under investigation
What is the main difference between retatrutide and tesamorelin